Protocols
Actionable longevity protocols backed by research: exercise, fasting, sleep, and recovery.
Biomarker use in protocols: measurement as a decision tool
How to use biomarker data to guide protocol adjustments, what to measure when, and where measurement misleads.
Combination logic: how interventions interact
Why longevity interventions cannot be stacked blindly, which combinations may be additive or counterproductive, and how to sequence.
Decision rules: when to start, stop, and adjust interventions
A framework for making protocol decisions based on evidence quality, personal risk tolerance, and measurable outcomes.
Dietary pattern and fasting strategies for longevity
What the evidence shows about caloric restriction, time-restricted eating, Mediterranean patterns, and protein cycling for healthspan.
Exercise as a longevity intervention: the strongest tool available
Why exercise remains the most evidence-backed longevity intervention, which modalities matter most, and minimum effective doses.
Exploratory layer: higher-risk interventions with emerging evidence
Rapamycin, senolytics, peptides, and other interventions that carry more uncertainty and require more caution.
Foundation layer: the non-negotiable base of any longevity protocol
Exercise, sleep, metabolic health, and stress regulation as the irreducible foundation before any supplement or intervention.
Foundation ranges and fit: practical targets for the base layer
Concrete ranges and targets for exercise, sleep, metabolic markers, and body composition that define a functional foundation.
Function-first logic: prioritizing what your body can do
Why functional capacity should drive protocol decisions more than molecular biomarkers, and how to structure around it.
Population fit: why one protocol does not fit everyone
How age, sex, genetics, health status, and goals should shape protocol design rather than following generic stacks.
Protocol failure modes: how longevity protocols break
Common patterns of protocol failure including complexity collapse, biomarker chasing, premature escalation, and confirmation bias.
Risk boundaries: where to draw the line on longevity interventions
How to define personal risk boundaries, what constitutes an acceptable experiment, and when to stop.
Risk hierarchy and translation limits
How to assess the risk-benefit profile of longevity interventions, why animal data often fails to translate, and where caution is required.
Sequencing and escalation: the order interventions should be added
Why the sequence of introducing longevity interventions matters, and how premature escalation creates unnecessary risk.
Sleep and recovery: the non-negotiable foundation
How sleep quality and recovery drive repair, immune function, cognitive health, and why sleep disruption accelerates aging.
Support layer: evidence-backed additions to the foundation
Targeted supplementation, biomarker tracking, and environmental optimization that sit above the foundation layer.
Zone 2 cardio for longevity: how much, how often, and why
The minimum effective dose, how to find your zone 2 threshold without lab testing, and what the endurance data shows.